8-K: Aveanna Healthcare Reports Strong Preliminary Q3 2025 Results

Aveanna Healthcare Holdings Inc. announced preliminary third-quarter 2025 financial results, projecting significant revenue, net income, and Adjusted EBITDA growth.

Summary

• Preliminary revenue for the three-month period ended September 27, 2025, is expected to be approximately $616 million to $624 million, representing growth of 21.0% to 22.6% over the prior year third quarter.
• Preliminary net income is anticipated to be approximately $11 million to $15 million, reflecting growth of 125.7% to 135.0% over the prior year third quarter.
• Preliminary Adjusted EBITDA is projected to be approximately $77 million to $81 million, indicating growth of 61.0% to 69.3% over the prior year third quarter.
• These financial and operational results are preliminary estimates and are subject to the completion of financial closing procedures and any adjustments from the quarterly review and finalization of consolidated financial statements.
• The independent registered public accounting firm has not audited, reviewed, or performed any procedures with respect to these preliminary results.

Sentiment

Score: 8

Explanation: The preliminary results show very strong growth across all key financial metrics (revenue, net income, Adjusted EBITDA), indicating robust operational performance. The significant year-over-year increases suggest positive momentum, despite the preliminary nature of the data and various adjustments.

Positives

• Strong projected revenue growth of 21.0% to 22.6% over the prior year third quarter.
• Significant anticipated net income growth of 125.7% to 135.0% compared to the prior year third quarter.
• Robust expected Adjusted EBITDA growth of 61.0% to 69.3% over the prior year third quarter.

Negatives

• The reported financial results are preliminary estimates and are subject to change, potentially materially, upon completion of financial closing procedures and review.
• The independent registered public accounting firm has not audited, reviewed, or performed any procedures on these preliminary results.
• Significant adjustments are made to reconcile net income to Adjusted EBITDA, including fees related to debt modifications ($15.65 million to $16.9 million) and loss on extinguishment of debt ($5.15 million to $6.6 million).
• Legal costs and settlements associated with acquisition matters, including costs to comply with a U.S. Department of Justice subpoena related to nurse wages and hiring activities ($1.3 million to $1.5 million), were incurred.

Risks

• Preliminary estimated results may differ materially from actual results that will be reflected in consolidated financial statements due to the completion of financial closing procedures and quarterly review.
• Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially, including those set forth in the Annual Report on Form 10-K for the 2024 fiscal year.

Future Outlook

The company expects to report strong preliminary financial results for the three-month period ended September 27, 2025, with significant growth across revenue, net income, and Adjusted EBITDA. However, these are preliminary estimates and are subject to change upon finalization of financial statements.

Management Comments

• Our expectations with respect to our unaudited results for the period discussed are based upon management estimates and are the responsibility of management.

Industry Context

The filing highlights Aveanna's position as a leading, diversified home care platform focused on medically complex, high-cost patient populations. The strong preliminary growth figures suggest robust demand for home healthcare services, potentially driven by an aging population and a broader industry shift towards lower-cost care alternatives to prolonged hospitalization.

Legal Proceedings

• Incurred costs of approximately $1.3 million to $1.5 million to comply with a U.S. Department of Justice, Antitrust Division's grand jury subpoena related to nurse wages and hiring activities in certain markets, in connection with a terminated transaction.

Stakeholder Impact

• Shareholders: Positive preliminary results could lead to increased investor confidence and potential share price appreciation, though the preliminary nature introduces some uncertainty.
• Employees: Restructuring and integration costs suggest potential changes in staffing or organizational structure, including salary, severance, and retention costs for duplicative personnel.
• Customers/Patients: Continued growth in services suggests ongoing demand for Aveanna's diversified home care platform.

Next Steps

• Completion of financial closing procedures and quarterly review for the three-month period ended September 27, 2025.
• Public disclosure of finalized consolidated financial statements for the third quarter of 2025.

Key Dates

Recommendation

The preliminary financial results indicate exceptionally strong growth across revenue, net income, and Adjusted EBITDA, significantly outperforming prior year figures. While these results are preliminary and subject to finalization, the magnitude of the projected growth suggests robust underlying business performance and market demand for Aveanna's diversified home care services. The company's focus on medically complex, high-cost patient populations positions it well within a growing healthcare segment. Despite the cautionary notes regarding the preliminary nature and various adjustments, the core operational strength reflected in these numbers makes it an attractive investment opportunity for growth-oriented investors.

Keywords

Aveanna Healthcare, AVAH, preliminary results, Q3 2025, financial results, revenue, net income, Adjusted EBITDA, home care, healthcare services, NASDAQ, SEC filing, 8-K